Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
Bristol-Myers Squibb(BMY) stock is priced at $55.81, giving the company a market capitalization of 114.69B. It carries a P/E multiple of 15.76 and pays a dividend yield of 4.5%.
During the trading session on 2026-05-09, Bristol-Myers Squibb(BMY) shares reached a daily high of $56.82 and a low of $55.78. At a current price of $55.81, the stock is +0.1% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 9.96M, compared to an average daily volume of 12.13M.
The stock's 52-week range extends from a low of $42.52 to a high of $62.89.
The stock's 52-week range extends from a low of $42.52 to a high of $62.89.
BMY News
European Commission approves Sotyktu (deucravacitinib) for adults with active psoriatic arthritis. First TYK2 inhibitor cleared for this indication in the Euro...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...
Analyst ratings
58%
of 31 ratingsMore BMY News
For investors wondering whether Bristol-Myers Squibb at around US$56.25 is offering value or risk at this point, this article breaks down what the current price...
Analyst Asad Haider from Goldman Sachs maintained a Hold rating on Bristol-Myers Squibb and keeping the price target at $61.00. Claim 55% Off TipRanks Unlock he...
Bristol-Myers Squibb (BMY) reported first quarter 2026 results that came in ahead of analyst expectations, with double digit growth from its newer drugs and a r...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.